Pharmacological differences between beta-blockers and postoperative mortality following colon cancer surgery

Pharmacological differences between beta-blockers and postoperative mortality following colon cancer surgery

Abstract β-blocker therapy has been positively associated with improved survival in patients undergoing oncologic colorectal resection. This study investigates if the type of β-blocker used affects 90-day postoperative mortality following colon cancer surgery. The study was designed as a nationwide...

Full description

Bibliographic Details
Main Authors: Lovisa Ekestubbe, Gary Alan Bass, Maximilian Peter Forssten, Gabriel Sjölin, Yang Cao, Peter Matthiessen, Rebecka Ahl Hulme, Shahin Mohseni
Format: Article
Language:English
Published: Nature Portfolio 2022-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-08736-6

Similar Items

Similar Items